138 related articles for article (PubMed ID: 28314168)
1. miR-137 downregulates c-kit expression in acute myeloid leukemia.
Hu Y; Dong X; Chu G; Lai G; Zhang B; Wang L; Zhao Y
Leuk Res; 2017 Jun; 57():72-77. PubMed ID: 28314168
[TBL] [Abstract][Full Text] [Related]
2. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.
Gao XN; Lin J; Gao L; Li YH; Wang LL; Yu L
Leuk Res; 2011 Sep; 35(9):1226-32. PubMed ID: 21724256
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.
Gao XN; Lin J; Li YH; Gao L; Wang XR; Wang W; Kang HY; Yan GT; Wang LL; Yu L
Oncogene; 2011 Aug; 30(31):3416-28. PubMed ID: 21399664
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia.
Xing CY; Hu XQ; Xie FY; Yu ZJ; Li HY; Bin-Zhou ; Wu JB; Tang LY; Gao SM
FEBS Lett; 2015 Jul; 589(15):1981-7. PubMed ID: 25979172
[TBL] [Abstract][Full Text] [Related]
7. Nobiletin Down-Regulates c-KIT Gene Expression and Exerts Antileukemic Effects on Human Acute Myeloid Leukemia Cells.
Chen PY; Chen YT; Gao WY; Wu MJ; Yen JH
J Agric Food Chem; 2018 Dec; 66(51):13423-13434. PubMed ID: 30507186
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia.
Wang X; Zuo D; Yuan Y; Yang X; Hong Z; Zhang R
J Cancer Res Clin Oncol; 2017 Jan; 143(1):169-180. PubMed ID: 27738758
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits.
Brioschi M; Fischer J; Cairoli R; Rossetti S; Pezzetti L; Nichelatti M; Turrini M; Corlazzoli F; Scarpati B; Morra E; Sacchi N; Beghini A
Neoplasia; 2010 Nov; 12(11):866-76. PubMed ID: 21076613
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA LINC00152 Facilitates the Leukemogenesis of Acute Myeloid Leukemia by Promoting CDK9 Through miR-193a.
Zhang X; Tao W
DNA Cell Biol; 2019 Mar; 38(3):236-242. PubMed ID: 30707636
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
[TBL] [Abstract][Full Text] [Related]
13. A minicircuitry comprised of microRNA-9 and SIRT1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
Zhou L; Fu L; Lv N; Chen XS; Liu J; Li Y; Xu QY; Huang S; Zhang XD; Dou LP; Wang LL; Li YH; Yu L
Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):786-794. PubMed ID: 28272704
[TBL] [Abstract][Full Text] [Related]
14. Interaction between 12p chromosomal abnormalities and Lnc-HOTAIR mediated pathway in acute myeloid leukemia.
El-Khazragy N; Ghozy S; Matbouly S; Zaki W; Safwat G; Hussien G; Khalifa O
J Cell Biochem; 2019 Sep; 120(9):15288-15296. PubMed ID: 31038787
[TBL] [Abstract][Full Text] [Related]
15. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
16. Targeting the RAS/MAPK pathway with miR-181a in acute myeloid leukemia.
Huang X; Schwind S; Santhanam R; Eisfeld AK; Chiang CL; Lankenau M; Yu B; Hoellerbauer P; Jin Y; Tarighat SS; Khalife J; Walker A; Perrotti D; Bloomfield CD; Wang H; Lee RJ; Lee LJ; Marcucci G
Oncotarget; 2016 Sep; 7(37):59273-59286. PubMed ID: 27517749
[TBL] [Abstract][Full Text] [Related]
17. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
Li G; Song Y; Zhang Y; Wang H; Xie J
Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
[TBL] [Abstract][Full Text] [Related]
18. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
19. miR-4792 Inhibits Acute Myeloid Leukemia Cell Proliferation and Invasion and Promotes Cell Apoptosis by Targeting Kindlin-3.
Qin Y; Wang Y; Liu D
Oncol Res; 2020 Sep; 28(4):357-369. PubMed ID: 32183929
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
